Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.
about
Circulating tumor cell count as a biomarker of a specific gastric cancer subgroup characterized by bone metastasis and/or disseminated intravascular coagulation - an early indicator of chemotherapeutic responseThe effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy.
P2860
Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Non-platinum-based chemotherap ...... acil, taxanes, and irinotecan.
@ast
Non-platinum-based chemotherap ...... acil, taxanes, and irinotecan.
@en
type
label
Non-platinum-based chemotherap ...... acil, taxanes, and irinotecan.
@ast
Non-platinum-based chemotherap ...... acil, taxanes, and irinotecan.
@en
prefLabel
Non-platinum-based chemotherap ...... acil, taxanes, and irinotecan.
@ast
Non-platinum-based chemotherap ...... acil, taxanes, and irinotecan.
@en
P2093
P2860
P356
P1476
Non-platinum-based chemotherap ...... acil, taxanes, and irinotecan.
@en
P2093
Byung Woog Kang
Ho Young Chung
Jong Gwang Kim
Oh-Kyoung Kwon
P2860
P304
P356
10.3748/WJG.V20.I18.5396
P407
P577
2014-05-01T00:00:00Z